Go to main content

University of Silesia in Katowice

  • Polski
  • English

Patent | Pancreatic cancer vs nanomedicine

08.08.2022 - 14:23 update 09.08.2022 - 11:26
Editors: MK

Scientists from the University of Silesia developed a new nanoconjugate using a pharmaceutical called gemcitabine with a powerful anti-cancer effect. This neurotherapeutic agent is characterised by excellent water solubility. Research has confirmed its effectiveness on selected pancreatic cancer and breast cancer cell lines. Based on that, scientists assume that it can be used in manufacturing pharmaceutical products, especially those used in the treatment of those two types of cancer. The solution is protected by patents. Its authors are: Maciej Serda, PhD Eng., Paweł Nalepa, MSc, Robert Gawecki, MSc, Anna Mrozek-Wilczkiewicz, PhD, DSc, Associate Professor, and Prof. Robert Musioł.

Laptop i słuchawki lekarskie

return to top